1,323,242 Shares in MetLife, Inc. $MET Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in MetLife, Inc. (NYSE:MET) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,323,242 shares of the financial services provider’s stock, valued at approximately $111,960,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MET. Norges Bank purchased a new stake in shares of MetLife during the fourth quarter worth $639,986,000. Vanguard Group Inc. raised its position in shares of MetLife by 12.1% in the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock valued at $5,727,518,000 after buying an additional 7,805,814 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of MetLife in the second quarter worth about $293,287,000. Pzena Investment Management LLC boosted its position in MetLife by 22.9% during the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock worth $938,071,000 after acquiring an additional 2,211,315 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in MetLife by 133.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 3,098,649 shares of the financial services provider’s stock worth $219,136,000 after acquiring an additional 1,771,689 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

Key MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Stock Performance

MetLife stock opened at $96.83 on Wednesday. The firm has a 50 day simple moving average of $92.00 and a 200-day simple moving average of $81.86. The stock has a market cap of $62.31 billion, a price-to-earnings ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $100.93.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the previous year, the company earned $2.02 EPS. The business’s revenue for the quarter was up 10.5% compared to the same quarter last year. On average, analysts expect that MetLife, Inc. will post 9.7 EPS for the current year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 annualized dividend and a yield of 2.4%. MetLife’s dividend payout ratio (DPR) is 45.40%.

MetLife declared that its board has authorized a share repurchase program on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to purchase up to 4.8% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. TD Cowen increased their price objective on shares of MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Barclays boosted their target price on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Jefferies Financial Group increased their price target on MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a report on Friday, July 10th. Piper Sandler lifted their price objective on MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Finally, JPMorgan Chase & Co. boosted their price objective on MetLife from $106.00 to $108.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $101.07.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.